CTOs on the Move

Sarepta

www.sarepta.com

 
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.sarepta.com
  • 215 First Street
    Cambridge, MA USA 02142
  • Phone: 617.274.4000

Executives

Name Title Contact Details
Christopher Jenkins
Director, IT End User Services Profile
Bill Thornton
Chief Information Officer Profile

Funding

Sarepta raised $40M on 06/26/2015
Sarepta raised $250M on 12/13/2019

Similar Companies

Maxim Healthcare Services

Maxim Healthcare Services, Inc. provides home healthcare, medical staffing, and wellness services across the U.S. Founded in 1988, Maxim is focused on delivering quality patient care and a commitment to employee development with an emphasis on customer service.

Fisher Center for Alzheimers Research Foundation

Fisher Center for Alzheimers Research Foundation is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Call9

Call9 is a technology company innovating medical services and systems in EmergencyMedicine and PalliativeCare.

Grant and Associates

Grant and Associates is a Olympia, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hoosier Oncology Group

Hoosier Oncology Group is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.